For primary biliary cirrhosis, ursodeoxycholic acid is safe and is the first choice for treatment. Treatment of this autoimmune liver disease should also address various symptoms and complications ...

Sorafenib is the standard treatment for patients with advanced ... survival has been demonstrated in patients with Child-Pugh A cirrhosis, information is lacking on the benefits, if any, in ...

A new study conducted by the Hepatitis Research Group at the Medical Research Council Unit The Gambia at the London School of ...

Liver cirrhosis is a late-stage liver disease characterized ... visible spider-like blood vessels, and palm redness.

Patient population for the NAVIGATE trial is based on non-invasive tests and clinical criteria utilizing latest treatment guidelines for portal ...

This chemopreventive activity became apparent 18-24 months after treatment initiation and increased over time,” the authors wrote. The lack of benefit in patients with established cirrhosis ...